A Comparison of Volatile Anesthesia and Total Intravenous Anesthesia (TIVA)
NCT ID: NCT04773002
Last Updated: 2022-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2021-03-18
2021-08-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TCI vs. Manuel TIVA in Septorhinoplasty Surgeries
NCT06957470
Controlled Sedoanalgesia in External DCR Surgery
NCT05397301
Preconditioning Volatile Anesthesia in Liver Surgery
NCT01021228
Evaluation of Oxygenation Parameters in Patients Undergoing Rhinoplasty Under General Anesthesia
NCT05754515
Effect of General Anesthesia Method on Cardiac Risk Patients on Ischemia Modified Markers
NCT05662163
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Group P (TIVA), induction of anesthesia will be achieved with 2 mg/kg propofol, 0.6 mg/kg rocuronium, and 1 μ / kg fentanyl. Propofol and remifentanil will be used in the continuation of anesthesia.
In Group S (Volatile), anesthesia will be induced with 2 mg / kg propofol, 0.6 mg / kg rocuronium and 1 μ / kg fentanyl. 50% nitrous oxide + 50% oxygen and 2% sevoflurane will be used in the continuation of anesthesia.
All patients will receive 2 ml/kg/hour Ringer's lactate solution during the operation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group P
Total intravenous anesthesia (TIVA)
Different anesthesia methods
Total intravenous anesthesia (TIVA)and volatile anesthesia
Group S
Volatile anestesia
Different anesthesia methods
Total intravenous anesthesia (TIVA)and volatile anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Different anesthesia methods
Total intravenous anesthesia (TIVA)and volatile anesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned to rhinoplasty
* An American Society of Anesthesiologists score of 1 or 2
Exclusion Criteria
* Patients with coagulation disorders, •Rejected to participation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tokat Gaziosmanpasa University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hakan Tapar
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muzaffer Katar
Role: STUDY_CHAIR
Gaziosmanpasa university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziosmanpasa University
Tokat Province, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-KAEK-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.